MNMD
Definium Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · CA
$20.69
+0.44%Institutional positioning
13F filings over the trailing two quarters
New 0Increased 1Reduced 0Sold out 7
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GOLDMAN SACHS GROUP INC | Increased | 925,332 | Mar 25, 2026 |
| KLP KAPITALFORVALTNING AS | Unchanged | 17,000 | Apr 29, 2026 |
| GOLDMAN SACHS GROUP INC | Sold Out | 0 | Mar 25, 2026 |
| KLP KAPITALFORVALTNING AS | Sold Out | 0 | Apr 29, 2026 |
| RATHBONES GROUP PLC | Sold Out | 0 | Jun 9, 2026 |
| MORGAN STANLEY | Sold Out | 0 | May 27, 2026 |
| CANDRIAM S.C.A. | Sold Out | 0 | Apr 30, 2026 |
| STRATEGIC WEALTH PARTNERS, LTD. | Sold Out | 0 | May 12, 2026 |
| Essential Partners LLC | Sold Out | 0 | May 21, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings